Form 4 Passage Bio Inc For: 22 July
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Passage Bio Inc (PASG)
Passage Bio Inc stock price live, this page displays NASDAQ PASG stock exchange data. View the PASG premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Passage Bio Inc real time stock price chart below.
What Is the Passage Bio Inc Stock Price Today?
The Passage Bio Inc stock price today is 4.6350.
What Is the Stock Symbol for Passage Bio Inc?
The stock symbol for Passage Bio Inc is "PASG."
What Stock Exchange Does Passage Bio Inc Trade On?
Passage Bio Inc is listed and trades on the NASDAQ stock exchange.
Is Passage Bio Inc a Good Stock to Buy?
Determining whether Passage Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PASG quote. (ISIN: US7027122099)
What Is the Passage Bio Inc Stock Price Today?
The Passage Bio Inc stock price today is 4.6350.
What Is the Stock Symbol for Passage Bio Inc?
The stock symbol for Passage Bio Inc is "PASG."
What Stock Exchange Does Passage Bio Inc Trade On?
Passage Bio Inc is listed and trades on the NASDAQ stock exchange.
Is Passage Bio Inc a Good Stock to Buy?
Determining whether Passage Bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PASG quote. (ISIN: US7027122099)
NASDAQ
Currency in USD
4.6350
+0.0650(+1.42%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.5000
4.6350
52 wk Range
3.2900
20.0000
Earnings results expected tomorrow
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.50004.6350
52 wk Range
3.290020.0000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PASG Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
15.5000
Upside
+234.41%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Form 10Q Passage Bio Inc For: 12 May- Investing.com
- Form 4 Passage Bio Inc For: 22 July
- Investing.com
Passage Bio Inc receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
1 Buy
2 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 15.5000
(+234.41% Upside)
Earnings
Latest Release
May 19, 2026
EPS / Forecast
-2.84 / -1.93
Revenue / Forecast
-- / --
Compare PASG to Peers and Sector
Metrics to compare | PASG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPASGPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.4x | −4.1x | −0.3x | |
PEG Ratio | −0.01 | −0.05 | 0.00 | |
Price/Book | 1.2x | 1.6x | 2.6x | |
Price / LTM Sales | - | 35.6x | 3.0x | |
Upside (Analyst Target) | 239.2% | 159.5% | 56.3% | |
Fair Value Upside | Unlock | 2.1% | 9.8% | Unlock |
Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; and PBKR03, for the treatment of Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other programs for huntington’s disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania’s Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. Passage Bio, Inc. was incorporated in 2017 and is based in Philadelphia, Pennsylvania.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Passage Bio (PASG) Stock Price Today?
The Passage Bio stock price today is 4.6350 USD.
What Stock Exchange Does Passage Bio Trade On?
Passage Bio is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Passage Bio?
The stock symbol for Passage Bio is "PASG."
What Is the Passage Bio Market Cap?
As of today, Passage Bio market cap is 14.8700M USD.
What Is Passage Bio's Earnings Per Share (TTM)?
The Passage Bio EPS (TTM) is -11.8353.
When Is the Next Passage Bio Earnings Date?
Passage Bio will release its next earnings report on Jul 30, 2026.
From a Technical Analysis Perspective, Is PASG a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Passage Bio Stock Split?
Passage Bio has split 1 times.
How Many Employees Does Passage Bio Have?
Passage Bio has 24 employees.
What is the current trading status of Passage Bio (PASG)?
As of Jul 29, 2026, Passage Bio (PASG) is trading at a price of 4.6350 USD, with a previous close of 4.5700 USD. The stock has fluctuated within a day range of 4.5000 USD to 4.6350 USD, while its 52-week range spans from 3.2900 USD to 20.0000 USD.
What Is Passage Bio (PASG) Price Target According to Analysts?
The average 12-month price target for Passage Bio is 15.5000 USD, with a high estimate of 23 USD and a low estimate of 8 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +234.41% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.